Avantor, Inc. (NYSE:AVTR - Free Report) - Investment analysts at Zacks Research boosted their Q2 2026 earnings per share estimates for shares of Avantor in a report released on Tuesday, December 10th. Zacks Research analyst D. Dey now expects that the company will post earnings per share of $0.29 for the quarter, up from their prior estimate of $0.28. The consensus estimate for Avantor's current full-year earnings is $0.98 per share.
Other equities analysts have also issued research reports about the company. UBS Group decreased their target price on Avantor from $30.00 to $29.00 and set a "buy" rating for the company in a research report on Tuesday, October 8th. Royal Bank of Canada reissued an "outperform" rating and set a $34.00 price objective on shares of Avantor in a report on Thursday, September 26th. Barclays lowered their price objective on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research report on Friday, October 25th. Robert W. Baird lowered their price target on Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a report on Monday, October 28th. Finally, Wells Fargo & Company cut their price objective on Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Monday, October 28th. Three research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $27.69.
Check Out Our Latest Report on AVTR
Shares of NYSE:AVTR opened at $22.53 on Friday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. Avantor has a 1 year low of $19.59 and a 1 year high of $28.00. The company has a market cap of $15.33 billion, a P/E ratio of 48.98, a PEG ratio of 2.59 and a beta of 1.29. The stock's fifty day moving average price is $22.53 and its 200-day moving average price is $23.54.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Hantz Financial Services Inc. boosted its stake in Avantor by 2.1% during the third quarter. Hantz Financial Services Inc. now owns 24,900 shares of the company's stock worth $644,000 after buying an additional 503 shares during the period. Intech Investment Management LLC boosted its position in Avantor by 1.8% in the 2nd quarter. Intech Investment Management LLC now owns 29,068 shares of the company's stock valued at $616,000 after buying an additional 514 shares during the period. Arizona State Retirement System grew its stake in Avantor by 0.3% in the 2nd quarter. Arizona State Retirement System now owns 186,567 shares of the company's stock worth $3,955,000 after acquiring an additional 528 shares in the last quarter. Veracity Capital LLC increased its position in shares of Avantor by 1.0% during the third quarter. Veracity Capital LLC now owns 52,359 shares of the company's stock worth $1,355,000 after acquiring an additional 543 shares during the period. Finally, Wealth Enhancement Advisory Services LLC raised its stake in shares of Avantor by 2.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company's stock valued at $571,000 after acquiring an additional 733 shares in the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.